This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Venous thromboembolism (VTE) and prostate cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Thromboembolism in men with prostate cancer

Population-based data suggest that the risk of VTE (venous thromboembolism) is twofold to threefold higher in men with prostate cancer than among men of similar age without cancer (1):

  • Van Hemelrijck et al showed that:
    • for men on endocrine therapy, risks for DVT (deep vein thrombosis) and pulmonary embolismwere increased, although this was not the case for arterial embolism
    • similar patterns were seen for men who received curative treatment and men who were on surveillance
    • increased risks for thromboembolic disease were maintained when patients were stratified by age and tumour stage

Also has been shown that prostate cancer patients are at a high risk of thromboembolism following surgical intervention (2):

  • surgeries for prostate cancer including TURP, are associated with hospitalization for thromboembolism. Patients with a history of thromboembolism and patients undergoing a pelvic lymph node dissection were at highest risk
  • largest risk was observed from days 14 to 28 postoperatively

A nationwide cohort study was undertaken to estimate the additional risk of venous thromboembolism (VTE) in men with prostate cancer compared with men without prostate cancer in Sweden (3):

  • following 92,105 men with prostate cancer and 466,241 men without prostate cancer (comparison cohort) matched 5:1 by birth year and residential region
  • showed that men with prostate cancer had a mean 50% increased risk of VTE during the 5 years following their cancer diagnosis compared with matched men free of prostate cancer

Reference:

  • Van Hemelrijck M et al. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol 2010;11:450-8.doi:10.1016/S1470-2045(10)70038-3pmid:http://www.ncbi.nlm.nih.gov/pubmed/20395174
  • Van Hemelrijck M et al.Thromboembolic events following surgery for prostate cancer. Eur Urol 2013;63:354-63.doi:10.1016/j.eururo.2012.09.041pmid:http://www.ncbi.nlm.nih.gov/pubmed/23021972
  • Balabanova Y, Farahmand B, Garmo H, et al.Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden.BMJ Open 2022;12:e055485. doi: 10.1136/bmjopen-2021-055485

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.